{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:39:13Z","timestamp":1792100353815,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Schistosomiasis paediatric consortium"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13071-016-1958-7","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T08:27:44Z","timestamp":1485419264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Efficacy and safety of praziquantel 40\u00a0mg\/kg in preschool-aged and school-aged children: a meta-analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Julien","family":"Zwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"1958_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411\u201325.","journal-title":"Lancet Infect Dis"},{"key":"1958_CR2","unstructured":"World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. 2006. Available: http:\/\/whqlibdoc.who.int\/publications\/2006\/9241547103_eng.pdf (Accessed 2 May 2014)."},{"key":"1958_CR3","unstructured":"World Health Organization. Assessing the Efficacy of Anthelminthic Drugs Against Schistosomiasis and Soil-Transmitted Helminthiases. 2013. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/79019\/1\/9789241564557_eng.pdf (Accessed June 2016)."},{"key":"1958_CR4","unstructured":"World Health Organization. Report of a meeting to review the results of studies on the treatment of schistosomiasis in pre-school-age children. 2010. Available: http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241501880_eng.pdf (Accessed 2 May 2014)."},{"key":"1958_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pt.2013.02.001","volume":"29","author":"JR Stothard","year":"2013","unstructured":"Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J. Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol. 2013;29:197\u2013205.","journal-title":"Trends Parasitol"},{"key":"1958_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2007.01.005","volume":"23","author":"JR Stothard","year":"2007","unstructured":"Stothard JR, Gabrielli AF. Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol. 2007;23:83\u20136.","journal-title":"Trends Parasitol"},{"key":"1958_CR7","unstructured":"World Health Assembly resolution. 2012. WHA65.21 http:\/\/www.who.int\/neglected_diseases\/Schistosomiasis_wha65\/en\/ . Accessed 2 June 2016."},{"key":"1958_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.inhe.2012.03.003","volume":"4","author":"JC Sousa-Figueiredo","year":"2012","unstructured":"Sousa-Figueiredo JC, Betson M, Stothard JR. Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole. Int Health. 2012;4:95\u2013102.","journal-title":"Int Health"},{"key":"1958_CR9","first-page":"25","volume":"5","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Schistosomiasis: number of people treated worldwide in 2013. Wkly Epidemiol Rec. 2015;5:25\u201332.","journal-title":"Wkly Epidemiol Rec"},{"key":"1958_CR10","doi-asserted-by":"crossref","unstructured":"Stothard JR, Sousa-Figueiredo JC, Navaratnam A. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis. Expert Rev Anti Infect Ther. 2013;11:733\u201352.","DOI":"10.1586\/14787210.2013.811931"},{"key":"1958_CR11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","volume":"69","author":"P Olliaro","year":"2014","unstructured":"Olliaro P, Delgado-Romero P, Keiser J. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J Antimicrob Chemother. 2014;69:863\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"1958_CR12","doi-asserted-by":"crossref","unstructured":"Danso-Appiah A, Olliaro P, Utzinger J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013;2:CD000528.","DOI":"10.1002\/14651858.CD000528.pub2"},{"key":"1958_CR13","first-page":"CD000053","volume":"8","author":"CV Kramer","year":"2014","unstructured":"Kramer CV, Zhang F, Sinclair D, Olliaro PL. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2014;8:CD000053.","journal-title":"Cochrane Database Syst Rev"},{"key":"1958_CR14","doi-asserted-by":"crossref","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","volume":"8","author":"J Zwang","year":"2014","unstructured":"Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8:e3286.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0169-4758(93)90132-Y","volume":"9","author":"SJ Vlas de","year":"1993","unstructured":"de Vlas SJ, Gryseels B, van Oortmarssen GJ, Polderman AM, Habbema JD. A pocket chart to estimate true Schistosoma mansoni prevalences. Parasitol Today. 1993;9:305\u20137.","journal-title":"Parasitol Today"},{"key":"1958_CR16","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"1958_CR17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1086\/657310","volume":"51","author":"S Knopp","year":"2010","unstructured":"Knopp S, Hattentorf J, Speich B, Rinaldi L, Mohammed KA, Khamis IS, et al. Diagnostic accuracy of Kato-Katz and FLOTAC for assessing anthelmintic drug efficacy. Clin Infect Dis. 2010;51:1420\u20138.","journal-title":"Clin Infect Dis"},{"key":"1958_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1958_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","volume":"323","author":"B Juni","year":"2001","unstructured":"Juni B, Altman DG. Egger M Systematic reviews of healthcare: assessing the quality of controlled clinical trials. BMJ. 2001;323:42\u20136.","journal-title":"BMJ"},{"key":"1958_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trstmh.2008.08.002","volume":"103","author":"PC Inyang-Etoh","year":"2009","unstructured":"Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg. 2009;103:38\u201344.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR21","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/bmj.39561.548924.94","volume":"336","author":"SJ Pocock","year":"2008","unstructured":"Pocock SJ, Travison TG, Wruck LM. How to interpret figures in reports of clinical trials. BMJ. 2008;336:1166\u20139.","journal-title":"BMJ"},{"key":"1958_CR22","doi-asserted-by":"crossref","first-page":"e1917","DOI":"10.1371\/journal.pntd.0001917","volume":"6","author":"JT Coulibaly","year":"2012","unstructured":"Coulibaly JT, N\u2019gbesso YK, Knopp S, Keiser J, N\u2019Goran EK, Utzinger J. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl Trop Dis. 2012;6:e1917.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.actatropica.2012.12.003","volume":"128","author":"A Garba","year":"2013","unstructured":"Garba A, Lamine MS, Djibo A, Tahirou A, Aouami MA, Alfari A, et al. Safety and efficacy of praziquantel syrup (Epiquantel\u00ae) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger. Acta Trop. 2013;128:318\u201325.","journal-title":"Acta Trop"},{"key":"1958_CR24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.trstmh.2012.03.013","volume":"106","author":"AM Navaratnam","year":"2012","unstructured":"Navaratnam AM, Sousa-Figueiredo JC, Stothard JR, Kabatereine NB, Fenwick A, Mutumba-Nakalembe MJ. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans R Soc Trop Med Hyg. 2012;106:400\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR25","doi-asserted-by":"crossref","first-page":"e0003796","DOI":"10.1371\/journal.pntd.0003796","volume":"9","author":"A Nalugwa","year":"2015","unstructured":"Nalugwa A, Nuwaha F, Tukahebwa EM, Olsen A. Single versus double dose praziquantel comparison on efficacy and schistosoma mansoni re-infection in preschool-age children in Uganda: a randomized controlled trial. PLoS Negl Trop Dis. 2015;9:e0003796.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR26","doi-asserted-by":"crossref","first-page":"e1864","DOI":"10.1371\/journal.pntd.0001864","volume":"6","author":"JC Sousa-Figueiredo","year":"2012","unstructured":"Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AM, Kabatereine NB, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis. 2012;6:e1864.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1086\/324004","volume":"184","author":"S Borrmann","year":"2001","unstructured":"Borrmann S, Szlezak N, Faucher JF, Matsiegui PB, Neubauer R, Binder RK, et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis. 2001;184:1363\u20136.","journal-title":"J Infect Dis"},{"key":"1958_CR28","first-page":"773","volume":"57","author":"A Davis","year":"1979","unstructured":"Davis A, Biles JE, Ulrich AM. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium. Bull World Health Organ. 1979;57:773\u20139.","journal-title":"Bull World Health Organ"},{"key":"1958_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0001-706X(02)00003-7","volume":"82","author":"D Clercq De","year":"2002","unstructured":"De Clercq D, Vercruysse J, Kongs A, Verl\u00e9 P, Dompnier JP, Faye PC. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 2002;82:61\u20136.","journal-title":"Acta Trop"},{"key":"1958_CR30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/651682","volume":"50","author":"J Keiser","year":"2010","unstructured":"Keiser J, N\u2019Guessan NA, Adoubryn KD, Silu\u00e9 KD, Vounatsou P, Hatz C. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis. 2010;50:1205\u201313.","journal-title":"Clin Infect Dis"},{"key":"1958_CR31","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pntd.0002975","volume":"8","author":"J Keiser","year":"2014","unstructured":"Keiser J, Silu\u00e9 KD, Adiossan LK, N\u2019Guessan NA, Monsan N, Utzinger J, et al. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl Trop Dis. 2014;8:e2975.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4269\/ajtmh.1990.43.170","volume":"43","author":"MC Latham","year":"1990","unstructured":"Latham MC, Stephenson LS, Kurz KM, Kinoti SN. Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections. Am J Trop Med Hyg. 1990;43:170\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR33","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/bmj.2.6202.1396","volume":"2","author":"JE McMahon","year":"1979","unstructured":"McMahon JE, Kolstrup N. Praziquantel: a new schistosomicide against Schistosoma haematobium. BMJ. 1979;2:1396\u20139.","journal-title":"BMJ"},{"key":"1958_CR34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.trstmh.2008.03.010","volume":"102","author":"N Midzi","year":"2008","unstructured":"Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, Munatsi A, et al. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg. 2008;102:759\u201366.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.68.24","volume":"68","author":"EK N\u2019Goran","year":"2003","unstructured":"N\u2019Goran EK, Utzinger J, Gnaka HN, Yapi A, N\u2019Guessan NA, Kigbafori SD, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg. 2003;68:24\u201332.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR36","first-page":"581","volume":"31","author":"AB Oyediran","year":"1981","unstructured":"Oyediran AB, Kofie BA, Bammeke AO, Bamgboye EA. Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium. Arzneimittelforschung. 1981;31:581\u20134.","journal-title":"Arzneimittelforschung"},{"key":"1958_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2049-9957-3-30","volume":"3","author":"O Ojurongbe","year":"2014","unstructured":"Ojurongbe O, Sina-Agbaje OR, Busari A, Okorie PN, Ojurongbe TA, Akindele AA. Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta. Nigeria Infect Dis Poverty. 2014;3:30.","journal-title":"Nigeria Infect Dis Poverty"},{"key":"1958_CR38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13149-013-0289-6","volume":"106","author":"M Ouldabdallahi","year":"2013","unstructured":"Ouldabdallahi M, Ousmane B, Ouldbezeid M, Mamadou D, Konat\u00e9 L, Chitsulo L. Comparison of the efficacy and safety of praziquantel administered in single dose of 40 versus 60 mg\/kg for treating urinary schistosomiasis in Mauritania. Bull Soc Pathol Exot. 2013;106:167\u20139.","journal-title":"Bull Soc Pathol Exot"},{"key":"1958_CR39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13071-015-0980-5","volume":"8","author":"B Senghor","year":"2015","unstructured":"Senghor B, Diaw OT, Doucoure S, Sylla SN, Seye M, Talla I, et al. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period. Parasit Vectors. 2015;8:362.","journal-title":"Parasit Vectors"},{"key":"1958_CR40","doi-asserted-by":"crossref","first-page":"e6732","DOI":"10.1371\/journal.pone.0006732","volume":"4","author":"MS Sissoko","year":"2009","unstructured":"Sissoko MS, Dabo A, Traore H, Diallo M, Traor\u00e9 B, Konat\u00e9 D, et al. Efficacy of artesunate\u2009+\u2009sulfamethoxypyrazine\/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One. 2009;4:e6732.","journal-title":"PLoS One"},{"key":"1958_CR41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1756-3305-5-298","volume":"5","author":"K Stete","year":"2012","unstructured":"Stete K, Krauth SJ, Coulibaly JT, Knopp S, Hattendorf J, M\u00fcller I, et al. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children. Parasit Vectors. 2012;5:298.","journal-title":"Parasit Vectors"},{"key":"1958_CR42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4269\/ajtmh.2004.71.778","volume":"71","author":"LA Tchuente","year":"2004","unstructured":"Tchuente LA, Shaw DJ, Polla L, Cioli D, Vercruysse J. Efficacy of praziquantel against Schistosoma haematobium infection in children. Am J Trop Med Hyg. 2004;71:778\u201382.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR43","first-page":"83","volume":"90","author":"HA Wilkins","year":"1987","unstructured":"Wilkins HA, Moore PJ. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia. J Trop Med Hyg. 1987;90:83\u201392.","journal-title":"J Trop Med Hyg"},{"key":"1958_CR44","first-page":"27","volume":"3","author":"VY Belizario Jr","year":"2008","unstructured":"Belizario Jr VY, Amarillo MLE, Martinez RM, Mallari AO, Tai CMC. Efficacy and safety of 40\u00a0mg\/kg and 60\u00a0mg\/kg single doses of praziquantel in the treatment of schistosomiasis. Pediatr Infect Dis J. 2008;3:27\u201334.","journal-title":"Pediatr Infect Dis J"},{"key":"1958_CR45","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1371\/journal.pntd.0001165","volume":"5","author":"PL Olliaro","year":"2011","unstructured":"Olliaro PL, Vaillant MT, Belizario VJ, Lwambo NJ, Ouldabdallahi M, Pieri OS, et al. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg\/kg vs. 60 mg\/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis. 2011;5:e1165.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR46","first-page":"309","volume":"179","author":"G Olds","year":"1998","unstructured":"Olds G, King C, Hewlett J, Olveda R, Wu G, Ouma J, et al. Double-blind placebo controlled study of the concurrent administration of albendazole and praziquantel in school-aged children infected with schistosomiasis. Am J Trop Med Hyg. 1998;179:309\u201310.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S003118201000154X","volume":"138","author":"R Barakat","year":"2011","unstructured":"Barakat R, El Morshedy H. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta. Egypt Parasitology. 2011;138:440\u20136.","journal-title":"Egypt Parasitology"},{"key":"1958_CR48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4269\/ajtmh.14-0675","volume":"92","author":"R Barakat","year":"2015","unstructured":"Barakat R, Abou El-Ela NE, Sharaf S, El Sagheer O, Selim S, Tallima H, et al. Efficacy and safety of arachidonic acid for treatment of school-age children in Schistosoma mansoni high-endemicity regions. Am J Trop Med Hyg. 2015;92:797\u2013804.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0001-706X(98)00084-9","volume":"72","author":"N Berhe","year":"1999","unstructured":"Berhe N, Gundersen SG, Abebe F, Birrie H, Medhin G, Gemetchu T. Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Trop. 1999;72:53\u201363.","journal-title":"Acta Trop"},{"key":"1958_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2005.72.119","volume":"72","author":"S Botros","year":"2005","unstructured":"Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M, et al. Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg. 2005;72:119\u201323.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0035-9203(02)90388-3","volume":"96","author":"G Degu","year":"2002","unstructured":"Degu G, Mengistu G, Jones J. Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia. Trans R Soc Trop Med Hyg. 2002;96:444\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2221-1691(12)60049-5","volume":"2","author":"B Erko","year":"2012","unstructured":"Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M. Efficacy and side effects of praziquantel in the treatment of schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia. Asian Pac J Trop Biomed. 2012;2:235\u20139.","journal-title":"Asian Pac J Trop Biomed"},{"key":"1958_CR53","first-page":"49","volume":"41","author":"H Friis","year":"1989","unstructured":"Friis H, Byskov J. The effect of praziquantel against Schistosoma mansoni-infections in Botswana. Trop Geogr Med. 1989;41:49\u201351.","journal-title":"Trop Geogr Med"},{"key":"1958_CR54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0035-9203(87)90439-1","volume":"81","author":"B Gryseels","year":"1987","unstructured":"Gryseels B, Nkulikyinka L, Coosemans MH. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Trans R Soc Trop Med Hyg. 1987;81:641\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4269\/ajtmh.1997.56.511","volume":"56","author":"F Guisse","year":"1997","unstructured":"Guisse F, Polman K, Stelma FF, Mbaye A, Talla I, Niang M, et al. Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal. Am J Trop Med Hyg. 1997;56:511\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR56","first-page":"119","volume":"87","author":"AA Massoud","year":"1984","unstructured":"Massoud AA, el Kholy AM, Anwar WA. Assessment of efficacy of praziquantel against Schistosoma mansoni infection. J Trop Med Hyg. 1984;87:119\u201321.","journal-title":"J Trop Med Hyg"},{"key":"1958_CR57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/1043-6618(95)80048-4","volume":"31","author":"A Metwally","year":"1995","unstructured":"Metwally A, Bennett J, Botros S, Ebeid F, el attar Gel D. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol Res. 1995;31:53\u20139.","journal-title":"Pharmacol Res"},{"key":"1958_CR58","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.trstmh.2009.01.026","volume":"103","author":"AA Mohamed","year":"2009","unstructured":"Mohamed AA, Mahgoub HM, Magzoub M, Gasim GI, Eldein WN, Ahmed Ael A, et al. Artesunate plus sulfadoxine\/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Trans R Soc Trop Med Hyg. 2009;103:1062\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1958_CR59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1473-3099(10)70161-4","volume":"10","author":"CO Obonyo","year":"2010","unstructured":"Obonyo CO, Muok EM, Mwinzi PN. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis. 2010;10:603\u201311.","journal-title":"Lancet Infect Dis"},{"key":"1958_CR60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4269\/ajtmh.14-0328","volume":"91","author":"S Selim","year":"2014","unstructured":"Selim S, El Sagheer O, El Amir A, Barakat R, Hadley K, Bruins MJ, et al. Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt. Am J Trop Med Hyg. 2014;91:973\u201381.","journal-title":"Am J Trop Med Hyg"},{"key":"1958_CR61","first-page":"532","volume":"67","author":"PE Simonsen","year":"1990","unstructured":"Simonsen PE, Nega A, Furu P. Intestinal schistosomiasis among children in a labour village of Wonji Sugar Estate, Ethiopia. East Afr Med J. 1990;67:532\u20138.","journal-title":"East Afr Med J"},{"key":"1958_CR62","first-page":"29","volume":"79","author":"FW Thiong\u2019o","year":"2002","unstructured":"Thiong\u2019o FW, Mbugua GG, Ouma JH, Sturrock RK. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas. East Afr Med J. 2002;79:29\u201333.","journal-title":"East Afr Med J"},{"key":"1958_CR63","first-page":"40","volume":"61","author":"CH Teesdale","year":"1984","unstructured":"Teesdale CH, Chitsulo L, Pugh RN. Oxamniquine dosage in Malawi. East Afr Med J. 1984;61:40\u20134.","journal-title":"East Afr Med J"},{"key":"1958_CR64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1365-3156.2000.00646.x","volume":"5","author":"J Utzinger","year":"2000","unstructured":"Utzinger J, N\u2019Goran EK, N\u2019Dri A, Lengeler C, Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health. 2000;5:771\u20138.","journal-title":"Trop Med Int Health"},{"key":"1958_CR65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00034983.1988.11812208","volume":"82","author":"M Tayeb El","year":"1988","unstructured":"El Tayeb M, Daffalla AA, Kardaman MW, See R, Fenwick A. Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and\/or Schistosoma haematobium in Gezira, Sudan. Ann Trop Med Parasitol. 1988;82:53\u20137.","journal-title":"Ann Trop Med Parasitol"},{"key":"1958_CR66","first-page":"105","volume":"88","author":"MW Kardaman","year":"1985","unstructured":"Kardaman MW, Fenwick A, El Igail AB, et al. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan. J Trop Med Hyg. 1985;88:105\u20139.","journal-title":"J Trop Med Hyg"},{"key":"1958_CR67","first-page":"13","volume":"91","author":"P Taylor","year":"1988","unstructured":"Taylor P, Murare HM, Manomano K. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium. J Trop Med Hyg. 1988;91:13\u20137.","journal-title":"J Trop Med Hyg"},{"key":"1958_CR68","first-page":"499","volume":"73","author":"WG Jaoko","year":"1996","unstructured":"Jaoko WG, Muchemi G, Oguya FO. Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi. Kenya East Afr Med. 1996;73:499\u2013501.","journal-title":"Kenya East Afr Med"},{"key":"1958_CR69","doi-asserted-by":"crossref","first-page":"e0003821","DOI":"10.1371\/journal.pntd.0003821","volume":"9","author":"PL Olliaro","year":"2015","unstructured":"Olliaro PL, Vaillant M, Diawara A, Coulibaly JT, Garba A, Keiser J, et al. Toward measuring schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion. PLoS Negl Trop Dis. 2015;9:e0003821.","journal-title":"PLoS Negl Trop Dis"},{"key":"1958_CR70","first-page":"9162631","volume":"2016","author":"WM Wami","year":"2016","unstructured":"Wami WM, Nausch N, Midzi N, Gwisai R, Mduluza T, Woolhouse ME, Mutapi F. Comparative assessment of health benefits of praziquantel treatment of urogenital schistosomiasis in preschool and primary school-aged children. Biomed Res Int. 2016;2016:9162631.","journal-title":"Biomed Res Int"},{"key":"1958_CR71","unstructured":"World Health Organization (WHO). Promoting safety of medicines for children. 2007. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/Promotion_safe_med_childrens.pdf Accessed 21 Sept 2016."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T20:43:23Z","timestamp":1568753003000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1958"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1958-7","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]},"article-number":"47"}}